Corporation MJN at the International Congress on Dravet Syndrome and Epilepsy 2019 Research on Dravet and refractory epilepsy doesn't stop. On October 3 and 4, we were able to hear live the…mjn-neuro25 October, 2019
Corporation MJN assists at Asebio InvestorDay 2019 On September 24th and 25th, our CEO, David Blánquez, was present at the second ASEBIO Investor Day.ASEBIO Investor Day is…mjn-neuro2 October, 2019
Corporation What are the Sustainable Development Goals (SDGs)? The Sustainable Development Goals, also known as Global Goals, were adopted by all United Nations Member States in 2015 as…mjn-neuro24 September, 2019
Corporación Innovación e investigación de calidad gracias al programa InnoCámaras de la Cámara de Comercio mjn-neuro16 September, 2019
Corporation MJN in the Social Innovation Tournament The Social Innovation Tournament recognises and supports the best European social entrepreneurs.mjn-neuro14 August, 2019
Corporation Theory of change: What is the social impact generation logic of mjn-neuro? Our project does not originate in a hospital research centre or a university. It is born from the grassroots, from…mjn-neuro8 July, 2019
Corporation MJN receives the Caser Award for Dependency and Society in the R+D category In its 10th edition, the Caser Foundation awards recognize the best initiatives in terms of dependency...mjn-neuro26 June, 2019
Corporación MJN en la II Feria Tecnológica para la Epilepsia EL pasado 23 de Mayo en Barcelona se celebró la 2ª edición de la feria tecnológica para la epilepsia organizada…mjn-neuro27 May, 2019
Corporation MJN at Mobile World Congress 2019 Last year we had the honour of winning the Vodafone Foundation prize for the best ICT Social Solution in the…mjn-neuro1 March, 2019
Corporation European Commission funds mjn-neuro under the SME Instrument Horizon2020 programme SME Instrument is part of the Horizon2020 programme and is a financing instrument promoted by the European Commission that aims…mjn-neuro16 January, 2019